(Q73715570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Movérare R

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Vesterinen E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Metso T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sorva R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Elfman L

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Haahtela T

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

337-342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

A controlled trial of immunotherapy for asthma in allergic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Fatalities from immunotherapy (IT) and skin testing (ST)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Determinants of patient compliance with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Systemic reactions occurring during immunotherapy with standardized pollen extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Immunotherapy to deciduous tree pollens: specific IgE and IgG antibody patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Immunological changes associated with a successful outcome of pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Immunologic and cellular changes accompanying the therapy of pollen allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Role of interleukin 10 in specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963310-8

7 January 2021

10.1016/S1081-1206(10)63310-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11289336%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference